Aeragen
New York City, United States · Founded 2021
- Headquarters
- New York City, New York
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Last Round
- Pre-SeedJan 2021
- Rounds
- 1
About
Aeragen is a medical device startup formed out of NYU dedicated to improving the standard of patient care by developing technologies that stop the spread of airborne infectious diseases. The company addresses longstanding issues in hospital, clinic, and EMS environments and beyond. Founded in 2021 under the NYU Technology Opportunities & Ventures program, Aeragen is listed as inactive on the NYU TOV startup portfolio page.
Summary
Aeragen is a Biotech company based in New York City, United States, founded in 2021. Its most recent funding was a Pre-Seed round in Jan 2021. Investors include Mount Sinai Innovation Partners.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2021
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.